More than 10 years survival with sequential therapy in a patient with advanced renal cell carcinoma: a case report

More than 10 years survival with sequential therapy in a patient with advanced renal cell carcinoma: a case report

Show other versions (1)

Although radical nephrectomy alone is widely accepted as the standard of care in localized treatment for renal cell carcinoma (RCC), it is not sufficient for the treatment of metastatic RCC (mRCC), which invariably leads to an unfavorable outcome despite the use of multiple therapies. Currently, seq...

Full description

Bibliographic Details
Main Authors: J.L. Yuan, F.L. Wang, X.M. Yi, W.J. Qin, G.J. Wu, Y. Huan, L.J. Yang, G. Zhang, L. Yu, Y.T. Zhang, R.L. Qin, C.J. Tian
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2014-10-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Metastatic renal cell carcinoma
Sequential therapy
Targeted anticancer agents
Sorafenib
Sunitinib
Immunotherapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000100034&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000100034&tlng=en

Similar Items